US EditionMerck Joins the Trump MFN Gang with IVF Deal
14 Articles
14 Articles
The US subsidiary EMD of the German pharmaceutical company Merck has agreed with the US government to reduce the cost of artificial fertilization, excluding the drugs from possible tax increases.
According to the agreement, if the three medicines selected are used together, the discount will be 84%. The American pharmaceutical subsidy, EMD Serono, will facilitate access to fertility treatments 'in vitro' to more than 10 million American women. In turn, the US will exempt prices on the pharmaceutical products of the company. However, Merck will have to invest in research and biopharmaceuticals in the United States. The announcement of thi…
Trump Unveils IVF Drug Pricing Deal to Boost U.S. Birthrate
In a dramatic policy push blending health care and demographics, President Donald Trump on Thursday unveiled a sweeping initiative to make in vitro fertilization (IVF) treatments more affordable—and reignite America’s declining birthrate. “We want more babies,” Trump declared, announcing a twin effort to encourage employers to offer fertility benefits and to slash drug prices through a new agreement with pharmaceutical manufacturer EMD Serono, a…
Trump Announces Deal to Cut IVF Drug Prices
President Donald Trump on Thursday announced new steps to make in vitro fertilization (IVF) treatments more affordable, unveiling a deal with major drug and pharmacy companies to lower the cost of a key fertility medication. The announcement marks the administration’s first major policy move on IVF since February, when Trump signed an executive order directing agencies to find ways to reduce treatment costs. But the latest measure stops short of…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
